CPC Subgroup
A61K 35/741 Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
Full Title
Medicinal preparations containing materials or reaction products thereof with undetermined constitution > Microorganisms or materials therefrom (fungi, yeasts or candida A61K36/06) > Bacteria (therapeutic use of a bacterial protein A61K38/00) > Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
2 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 35/742 Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
- A61K 35/744 Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513